Evermay Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $262K | Hold |
645
| – | – | 0.03% | 177 |
|
|
2025
Q1 | $321K | Sell |
645
-15
| -2% | -$7.47K | 0.04% | 158 |
|
|
2024
Q4 | $344K | Sell |
660
-115
| -15% | -$59.9K | 0.05% | 149 |
|
|
2024
Q3 | $480K | Sell |
775
-5
| -0.6% | -$3.09K | 0.08% | 127 |
|
|
2024
Q2 | $432K | Hold |
780
| – | – | 0.07% | 137 |
|
|
2024
Q1 | $454K | Buy |
780
+44
| +6% | +$25.6K | 0.07% | 135 |
|
|
2023
Q4 | $391K | Sell |
736
-49
| -6% | -$26K | 0.07% | 121 |
|
|
2023
Q3 | $398K | Buy |
785
+17
| +2% | +$8.61K | 0.08% | 112 |
|
|
2023
Q2 | $401K | Sell |
768
-21
| -3% | -$11K | 0.08% | 121 |
|
|
2023
Q1 | $455K | Buy |
789
+36
| +5% | +$20.8K | 0.09% | 101 |
|
|
2022
Q4 | $415K | Sell |
753
-57
| -7% | -$31.4K | 0.08% | 109 |
|
|
2022
Q3 | $411K | Buy |
810
+2
| +0.2% | +$1.02K | 0.08% | 107 |
|
|
2022
Q2 | $439K | Buy |
808
+19
| +2% | +$10.3K | 0.09% | 96 |
|
|
2022
Q1 | $466K | Sell |
789
-174
| -18% | -$103K | 0.08% | 116 |
|
|
2021
Q4 | $643K | Hold |
963
| – | – | 0.11% | 74 |
|
|
2021
Q3 | $550K | Sell |
963
-177
| -16% | -$101K | 0.11% | 80 |
|
|
2021
Q2 | $575K | Sell |
1,140
-15
| -1% | -$7.57K | 0.11% | 84 |
|
|
2021
Q1 | $527K | Sell |
1,155
-64
| -5% | -$29.2K | 0.11% | 88 |
|
|
2020
Q4 | $568K | Buy |
1,219
+130
| +12% | +$60.6K | 0.13% | 75 |
|
|
2020
Q3 | $481K | Hold |
1,089
| – | – | 0.12% | 80 |
|
|
2020
Q2 | $395K | Sell |
1,089
-10
| -0.9% | -$3.63K | 0.1% | 92 |
|
|
2020
Q1 | $312K | Hold |
1,099
| – | – | 0.09% | 97 |
|
|
2019
Q4 | $357K | Hold |
1,099
| – | – | 0.09% | 108 |
|
|
2019
Q3 | $320K | Buy |
1,099
+230
| +26% | +$67K | 0.09% | 109 |
|
|
2019
Q2 | $255K | Sell |
869
-4
| -0.5% | -$1.17K | 0.07% | 128 |
|
|
2019
Q1 | $239K | Buy |
+873
| New | +$239K | 0.07% | 129 |
|
|
2018
Q4 | – | Sell |
-839
| Closed | -$205K | – | 149 |
|
|
2018
Q3 | $205K | Buy |
+839
| New | +$205K | 0.06% | 144 |
|